Corante

In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Corante New York

« The U.S. Military Academy declares war on Internet scammers | Main | The Data and Information Guru »

August 23, 2005

OSI Pharmaceuticals to acquire Eyetech

Email This Entry

Posted by Dominic Basulto

OSI Pharma.gif

Long Island-based OSI Pharmaceuticals will acquire Eyetech Pharmaceuticals, which has offices in Times Square, for approximately $935 million in stock and cash. OSI Pharmaceuticals specializes in cancer treatments while Eyetech makes the age-related macular degeneration treatment Macugen. According to the terms of the deal, OSI will pay $20 per share for Eyetech, a 43% premium to the stock's closing price of $13.99 on Friday.

Comments (0) + TrackBacks (0) | Category: Deals


TrackBack URL:
http://www.corante.com/cgi-bin/mt/external.cgi/31633


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
East Village bar up for sale on eBay
Eliot Spitzer takes on the national cinema chains
California winemakers to sell wine to New Yorkers via the Internet
A blogger could become "Media Person of the Year"
A la carte cable TV pricing
NYSIA Incubator launch party tonight
Why the mathematics of congestion pricing don't work
Enjoy the holiday shopping bargains at Century 21 while you can